O‐GlcNAcylation of TDP‐43 suppresses proteinopathies and promotes TDP‐43’s mRNA splicing activity
Meng‐Jie Zhao,Xiao Yao,Ping Wei,Chen Zhao,Meng Cheng,Dong Zhang,Wen Xue,Wen‐Tian He,Weili Xue,Xinxin Zuo,Lei‐Lei Jiang,Zhiyuan Luo,Jiaqi Song,Wen‐Jie Shu,Han‐Ye Yuan,Yi Liang,Hui Sun,Yan Zhou,Yu Zhou,Ling Zheng,Hong‐Yu Hu,Jiwu Wang,Hai‐Ning Du
DOI: https://doi.org/10.15252/embr.202051649
IF: 9.071
2021-04-15
EMBO Reports
Abstract:<p>Pathological TDP‐43 aggregation is characteristic of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD‐TDP); however, how TDP‐43 aggregation and function are regulated remain poorly understood. Here, we show that O‐GlcNAc transferase OGT‐mediated O‐GlcNAcylation of TDP‐43 suppresses ALS‐associated proteinopathies and promotes TDP‐43's splicing function. Biochemical and cell‐based assays indicate that OGT's catalytic activity suppresses TDP‐43 aggregation and hyperphosphorylation, whereas abolishment of TDP‐43 O‐GlcNAcylation impairs its RNA splicing activity. We further show that TDP‐43 mutations in the O‐GlcNAcylation sites improve locomotion defects of larvae and adult flies and extend adult life spans, following TDP‐43 overexpression in Drosophila motor neurons. We finally demonstrate that O‐GlcNAcylation of TDP‐43 promotes proper splicing of many mRNAs, including STMN2, which is required for normal axonal outgrowth and regeneration. Our findings suggest that O‐GlcNAcylation might be a target for the treatment of TDP‐43‐linked pathogenesis.</p>
cell biology,biochemistry & molecular biology